The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| AMERICAN CENTY ETF TR | US SML CP VALU | 025072877 | 23,043,289 | 245,900 | SH | SOLE | 245,900 | 0 | 0 | |||
| ATAI LIFE SCIENCES NV | SHS | N0731H103 | 1,415,445 | 718,500 | SH | SOLE | 718,500 | 0 | 0 | |||
| BLUE OWL CAPITAL CORPORATION | COM | 69121K104 | 56,732,621 | 3,688,727 | SH | SOLE | 3,688,727 | 0 | 0 | |||
| BLUE OWL CAP CORP III | COM SHS | 69122G102 | 10,341,858 | 675,056 | SH | SOLE | 675,056 | 0 | 0 | |||
| BLUE OWL CAPITAL INC | COM CL A | 09581B103 | 131,297,473 | 6,961,690 | SH | SOLE | 6,961,690 | 0 | 0 | |||
| COMPASS PATHWAYS PLC | SPONSORED ADS | 20451W101 | 604,864 | 72,700 | SH | SOLE | 72,700 | 0 | 0 | |||
| ISHARES INC | MSCI JPN ETF NEW | 46434G822 | 17,291,673 | 242,350 | SH | SOLE | 242,350 | 0 | 0 | |||
| KE HLDGS INC | SPONSORED ADS | 482497104 | 6,021,237 | 438,546 | SH | SOLE | 438,546 | 0 | 0 | |||
| PROKIDNEY CORP | CLASS A ORD SHS | G7S53R104 | 1,640,000 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | |||
| SPDR SER TR | S&P BIOTECH | 78464A870 | 2,846,700 | 30,000 | SH | SOLE | 30,000 | 0 | 0 | |||